These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2430051)

  • 1. Comparison of the neutralizing and ELISA antibody titres to human cytomegalovirus (HCMV) in human sera and in gamma globulin preparations.
    Schmitz H; Essuman S
    J Med Virol; 1986 Oct; 20(2):177-82. PubMed ID: 2430051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid (24h) neutralization assay for the detection of antibodies to human cytomegalovirus using a monoclonal antibody to an HCMV early nuclear protein.
    Braun W; Schacherer C
    J Virol Methods; 1988 Oct; 22(1):31-40. PubMed ID: 2848858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
    Miescher SM; Huber TM; Kühne M; Lieby P; Snydman DR; Vensak JL; Berger M
    Vox Sang; 2015 Jul; 109(1):71-8. PubMed ID: 25766313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.
    Weber B; Braun W; Cinatl J; Doerr HW
    Clin Investig; 1993 Apr; 71(4):270-6. PubMed ID: 8386033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells.
    Wang X; Peden K; Murata H
    Vaccine; 2015 Dec; 33(51):7254-7261. PubMed ID: 26552003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An enzyme immunoassay based micro-neutralization test for titration of antibodies to human cytomegalovirus (CMV) and its correlation with direct ELISA measuring CMV IgG antibodies.
    Gupta CK; Leszczynski J; Gupta RK; Siber GR
    Biologicals; 1996 Mar; 24(1):41-9. PubMed ID: 8733600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of CMV ELISA antibody: titer and neutralizing activity in intramuscular immune globulin of placental origin.
    Gibert R; el Habib R; Allard JP; Defayolle M; Aymard M
    Transplant Proc; 1987 Oct; 19(5):4083-6. PubMed ID: 2823436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.
    Bruno F; Fornara C; Zelini P; Furione M; Carrara E; Scaramuzzi L; Cane I; Mele F; Sallusto F; Lilleri D; Gerna G
    J Gen Virol; 2016 Aug; 97(8):1928-1941. PubMed ID: 27113912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
    Planitzer CB; Saemann MD; Gajek H; Farcet MR; Kreil TR
    Transplantation; 2011 Aug; 92(3):267-70. PubMed ID: 21659947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus.
    Kropff B; Landini MP; Mach M
    J Med Virol; 1993 Mar; 39(3):187-95. PubMed ID: 8385703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
    Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.
    Chehimi J; Peppard J; Emanuel D
    Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities.
    Gupta CK; Leszczynski J; Gupta RK; Siber GR
    Biologicals; 1996 Jun; 24(2):117-24. PubMed ID: 8889058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations.
    Rabenau HF; Marianov B; Wicker S; Allwinn R
    Med Microbiol Immunol; 2007 Sep; 196(3):151-5. PubMed ID: 17308917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedure for evaluation of neutralizing antibody to cytomegalovirus in commercial intravenous gamma globulin preparations.
    Wordell C; Chambers L; Durante M; DiRenzo S; Hopkins L; Jungkind D
    Adv Exp Med Biol; 1992; 312():173-82. PubMed ID: 1325103
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative determination of cytomegalovirus IgG antibody by enzyme-linked immunosorbent assay (ELISA).
    Chia WK; Spence L
    Can J Microbiol; 1979 Sep; 25(9):1082-6. PubMed ID: 232004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
    Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
    J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.
    Marshall GS; Rabalais GP; Stout GG; Waldeyer SL
    J Infect Dis; 1992 Feb; 165(2):381-4. PubMed ID: 1309850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme linked immunosorbent assay (ELISA) for cytomegalovirus antibody in donor plasma.
    Ramskill S; Senior P; Barlow P; Tovey LA
    J Clin Pathol; 1988 Nov; 41(11):1233-5. PubMed ID: 2850301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells.
    Funaro A; Gribaudo G; Luganini A; Ortolan E; Lo Buono N; Vicenzi E; Cassetta L; Landolfo S; Buick R; Falciola L; Murphy M; Garotta G; Malavasi F
    BMC Biotechnol; 2008 Nov; 8():85. PubMed ID: 19014469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.